Microbial metabolites that regulate osteoclast differentiation and function

调节破骨细胞分化和功能的微生物代谢产物

基本信息

  • 批准号:
    11660078
  • 负责人:
  • 金额:
    $ 2.37万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

To obtain new insights into the mechanisms of differentiation and function of osteoclasts and to develop natural compounds as anti-resortive medicines for clinical application, we have screened microbial metabolites for low molecular weight compounds that inhibit the differentiation and function of osteoclasts. In the process of this screening we found compactin, destruxins and reveromycin A.Compactin inhibited the fusion process of prefusion osteoclasts into multinucleated osteoclasts, disrupted the actin ring of osteoclasts and inhibited bone resorption. The effects of compactin were suppressed by the addition of mevalonic acid lactone or its downastream products including farnesylpyrophosphate and gerahylgeranyl-pyrophosphate, but not by squalene. The results indicate that these effects of compactin are the consequence of the inhibition of prenylation of proteins that play an important role in the fusion process of preosteoclasts and in maintaining the actin ring integrity in osteoclasts. Destruxins, which are cyclomonodepsipeptides isolated from the antomogenous fungi, reversibly inhibited bone resorption through disrupting morphological structures including the actin ring in activated osteoclasts and inhibiting the polarization of osteoclasts on the bone without affecting viability of osteoclasts. They also affected the localization of c-src and a3 subunit of V-ATPase that are essential molecules osteoclasts. These results suggest that destruxins regulate polarization of osteoclasts. Reveromycin A induced apoptosis specifically in mature activated osteoclasts through release of mitochodrial cytochrome c into cytosol, and inhibited bone resorption. The specific effect of reveromycin A on activated osteoclasts was related to the acidic condition around membrane of activated osteoclasts.
为了获得破骨细胞分化和功能机制的新见解,并开发天然化合物作为临床应用的抗吸收药物,我们筛选了微生物代谢产物中抑制破骨细胞分化和功能的低分子量化合物。在这个筛选过程中,我们发现compactin,destruxins和reveromycin A.Compactin抑制融合前破骨细胞融合成多核破骨细胞,破坏破骨细胞的肌动蛋白环,抑制骨吸收。甲羟戊酸内酯或其下游产物法尼基焦磷酸和香叶基香叶基焦磷酸可抑制甲羟戊酸内酯的作用,但角鲨烯不抑制甲羟戊酸内酯的作用。结果表明,这些影响的compactin的异戊二烯化的蛋白质,在破骨细胞前体的融合过程中发挥重要作用,并在维持肌动蛋白环的完整性破骨细胞的抑制的后果。破坏素是从内生真菌中分离的环单缩酚肽,通过破坏包括活化的破骨细胞中的肌动蛋白环在内的形态结构和抑制破骨细胞在骨上的极化而不影响破骨细胞的活力,可逆地抑制骨吸收。它们还影响破骨细胞所必需的c-src和V-ATP酶α 3亚基的定位。这些结果表明,destruxins调节破骨细胞的极化。逆转霉素A通过释放线粒体细胞色素c到胞浆中,特异性地诱导成熟活化的破骨细胞凋亡,并抑制骨吸收。回复霉素A对活化破骨细胞的特异性作用与活化破骨细胞膜周围的酸性条件有关。

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
J.-T.Woo: "RANKL and IL-1 induce the fusion of mononuclear preosteoclasts into multinucleated osteoclasts through their receptors by activating NF-κB."Cytotechnology. 33. 203-211 (2000)
J.-T.Woo:“RANKL 和 IL-1 通过激活 NF-κB,通过其受体诱导单核前破骨细胞融合为多核破骨细胞。”Cytotechnology。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
J.-T.Woo, M.Takami, and K.Nagai: "RANKL and IL-1 induce the fusion of mononuclear preosteoclasts into multinucleated osteoclasts through their receptors by activating NF-kappaB."Cytotechnology. 33. 203-211 (2000)
J.-T.Woo、M.Takami 和 K.Nagai:“RANKL 和 IL-1 通过激活 NF-kappaB,通过其受体诱导单核前破骨细胞融合为多核破骨细胞。”细胞技术。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Takami: "Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kB ligand andosteoprotegerin in osteoclasts."Endocrinology. 141. 4711-4719 (2000)
M.Takami:“细胞内钙和蛋白激酶 C 介导破骨细胞中核因子-kB 配体受体激活剂和骨保护素的表达。”内分泌学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Takami, J.-T.Woo and K.Nagai: "Osteoblastic cells induce fusion and activation of osteoclasts through a mechanism independent of macrophage-colony-stimulating factor production."Cell Tissue Res.. 298. 324-334 (1999)
M.Takami、J.-T.Woo 和 K.Nagai:“成骨细胞通过独立于巨噬细胞集落刺激因子产生的机制诱导破骨细胞融合和激活。”Cell Tissue Res.. 298. 324-334 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Takami: "Osteoblastic cells induce fusion and activation of osteoclasts through a mechanism independent of macrophage-colony-stimulating factor production"Cell Tissue Res.. 298. 327-342 (1999)
M.Takami:“成骨细胞通过独立于巨噬细胞集落刺激因子产生的机制诱导破骨细胞融合和激活”细胞组织研究298. 327-342 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAGAI Kazuo其他文献

NAGAI Kazuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAGAI Kazuo', 18)}}的其他基金

Effects of Low Molecular Weight Compounds on Osteoclastic Bone Resorption in vivo and in vitro.
低分子量化合物对体内和体外破骨细胞骨吸收的影响。
  • 批准号:
    15380077
  • 财政年份:
    2003
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Low Molecular Weight Compounds That Regulate Bone Metabolism
调节骨代谢的低分子量化合物
  • 批准号:
    13460036
  • 财政年份:
    2001
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on physiological functions of vacuolar type H^+-ATPase using low molecular weight probes
低分子探针研究液泡型H^-ATP酶的生理功能
  • 批准号:
    09460047
  • 财政年份:
    1997
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Roles of protein phosphorylation, calcium ion and cytoskeltal proteins in bacterial cell cycle.
蛋白质磷酸化、钙离子和细胞骨架蛋白在细菌细胞周期中的作用。
  • 批准号:
    05453161
  • 财政年份:
    1993
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Studies on regulatory factors for bacterial cell cycle.
细菌细胞周期调控因子的研究。
  • 批准号:
    03453137
  • 财政年份:
    1991
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Elucidation of bone resorption mechanism around implants caused by microgap dissection and establishment of suppression method
微间隙剥离引起种植体周围骨吸收机制的阐明及抑制方法的建立
  • 批准号:
    22K10080
  • 财政年份:
    2022
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CAN OSTEOCLAST BIOMARKERS DETECT EXCESSIVE SUBCHONDRAL BONE RESORPTION IN RACEHORSES?
破骨细胞生物标志物可以检测赛马过度的软骨下骨吸收吗?
  • 批准号:
    RGPIN-2019-04966
  • 财政年份:
    2022
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Discovery Grants Program - Individual
Mechanisms of bone resorption in the cancer microenvironment.
癌症微环境中的骨吸收机制。
  • 批准号:
    22K10145
  • 财政年份:
    2022
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Secretory mechanism of GMSC derved exosomes and suppression of bone resorption by internalizing miRNA
GMSC 衍生的外泌体的分泌机制和通过内化 miRNA 抑制骨吸收
  • 批准号:
    21K21017
  • 财政年份:
    2021
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Bone Marrow Inflammation and Bone Resorption
骨髓炎症和骨吸收
  • 批准号:
    10295620
  • 财政年份:
    2021
  • 资助金额:
    $ 2.37万
  • 项目类别:
CAN OSTEOCLAST BIOMARKERS DETECT EXCESSIVE SUBCHONDRAL BONE RESORPTION IN RACEHORSES?
破骨细胞生物标志物可以检测赛马过度的软骨下骨吸收吗?
  • 批准号:
    RGPIN-2019-04966
  • 财政年份:
    2021
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Discovery Grants Program - Individual
Bone Marrow Inflammation and Bone Resorption
骨髓炎症和骨吸收
  • 批准号:
    10673929
  • 财政年份:
    2021
  • 资助金额:
    $ 2.37万
  • 项目类别:
A new model for spatio-temporal coupling of bone formation and bone resorption governed by osteoclasts
破骨细胞控制的骨形成和骨吸收时空耦合的新模型
  • 批准号:
    10905262
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
The Myokine Irisin Modulates Bone Resorption via Stimulation of Osteoclastogenesis
肌动素鸢尾素通过刺激破骨细胞生成调节骨吸收
  • 批准号:
    10228556
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
CAN OSTEOCLAST BIOMARKERS DETECT EXCESSIVE SUBCHONDRAL BONE RESORPTION IN RACEHORSES?
破骨细胞生物标志物可以检测赛马过度的软骨下骨吸收吗?
  • 批准号:
    RGPIN-2019-04966
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了